LEAP THERAPEUTICS, INC. (16)

Browse by Contract Category

Contracts

Employment Agreement, by and between the Company and Cynthia Sirard, dated as of April 10, 2020 (Filed With SEC on March 12, 2021)
Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on June 18, 2020)
Exclusive Option and License Agreement dated as of January 3, 2020, by and between the Company and BeiGene, Ltd (Filed With SEC on May 14, 2020)
Description of the Registrant's Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)
Employment Agreement, by and between the Company and John Mark O Mahony, dated as of April 10, 2020 (Filed With SEC on March 12, 2021)
Employment Agreement, by and between the Company and Christine Granfield, dated as of August 16, 2020 (Filed With SEC on November 12, 2020)
Underwriting Agreement, dated June 18, 2020, by and among Leap Therapeutics, Inc. and Piper Sandler & Co. and Raymond James & Associates, Inc., as representatives of the... (Filed With SEC on June 18, 2020)
Employment Agreement, by and between the Company and Douglas E. Onsi, dated as of April 10, 2020 (Filed With SEC on April 15, 2020)
Form of Pre-Funded Warrant (Filed With SEC on January 7, 2020)
Form of Series A Coverage Warrant (Filed With SEC on January 7, 2020)
Form of Series B Coverage Warrant (Filed With SEC on January 7, 2020)
Purchase Agreement dated as of July 11, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
Purchase Agreement dated as of July 10, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
Registration Rights Agreement dated as of July 10, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
Underwriting Agreement, dated February 1, 2019, by and among Leap Therapeutics, Inc., Raymond James & Associates, Inc. and Ladenburg Thalmann & Co. Inc., as representatives of the... (Filed With SEC on February 1, 2019)
Form of Warrant (Filed With SEC on February 1, 2019)